TIP_link_300x300.jpg
Encapsulation Market Size ($80,071.65Mn by 2028) Driven by Food and Beverages (12.5% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
03 nov. 2021 14h46 HE | The Insight Partners
New York, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Encapsulation Market: Key InsightsAccording to our new research study on Encapsulation Market Size, Share, Revenue, Forecast to 2028 - COVID-19 Impact and...
retro.jpg
Retrotope Reports Data from Phase 2/3 Clinical Trial of RT001 and Concurrent Natural History Study in Patients with Infantile Neuroaxonal Dystrophy (INAD)
06 oct. 2021 07h00 HE | Retrotope
Treatment with RT001 Results in Statistically Significant Improvements in Overall Survival and Progression Free Survival for INAD Patients as Compared to Control Benefits Supported by Totality of...
ARC logo.png
Pharmaceutical Lipids Market Is Forecasted To Represent Noteworthy Share During Forecast Period 2021-2028: Acumen Research And Consulting
25 août 2021 11h09 HE | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Pharmaceutical Lipids Market – Global Industry Analysis, Market Size,...
retro.jpg
Retrotope Announces Completion of Enrollment in Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
11 août 2021 07h00 HE | Retrotope
LOS ALTOS, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
Esperion Logo (primary).png
Esperion Announces Commercial Availability of NEXLIZET™ (bempedoic acid and ezetimibe) Tablets and Ushers in New Era of Oral Combination Medicine for LDL-Cholesterol Lowering
04 juin 2020 07h00 HE | Esperion Therapeutics, Inc.
– First-Ever Non-Statin Combination Medicine, Providing 38 Percent Mean LDL-C Lowering – – Esperion Aims to Set New Industry Standard by Pricing NEXLIZET for Patient Affordability and Access with...
RND logo.PNG
Jojoba oil Market to Reach USD 272.4 Million By 2026 | Reports And Data
09 avr. 2019 12h11 HE | Reports And Data
Rising cosmetic industry across the globe will boost Market growth. Market Size – USD 187.8 Million in 2018, Market Growth - CAGR of 5.0%, Market Trends – The increasing use of jojoba oil in...
ACC, AHA Release 2018 Guideline on the Management of Blood Cholesterol at AHA Scientific Sessions
10 nov. 2018 12h55 HE | National Lipid Association
NLA among 12 organizations to co-author, endorse key document for reducing risk of atherosclerotic cardiovascular disease CHICAGO, Nov. 10, 2018 (GLOBE NEWSWIRE) -- The American College of...
NLA LOGO - USE.png
PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference
07 févr. 2017 09h30 HE | National Lipid Association
PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...
admera_health_final_logo_transparent_final.jpg
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
17 mars 2016 07h00 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...
NLA LOGO - USE.png
New Joint Scientific Statement Issued on Use of Bariatric Surgery to Improve Cholesterol Levels and Reduce Risk of Heart Disease JACKSONVILLE, FL --(Marketwired - February 16, 2016) - Bariatric surgery is effective in improving cholesterol and lipid levels, important risk factors for heart disease, according to a new joint...